Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Chebib

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
British Journal of Pharmacology|August 12, 2021
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsyLyndsey L Anderson, Marika Heblinski, Nathan L Absalom, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2024
Understanding paralogous epilepsy-associated GABA<sub>A</sub> receptor variants: Clinical implications, mechanisms, and potential pitfallsAnthony S H Kan, Ali S Kusay, Nazanin A Mohammadi, et al.
Epilepsia|June 2, 2026
Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variantsCathrine E Gjerulfsen, Vivian W Y Liao, Tomasz S Mieszczanek, et al.
Journal of Medicinal Chemistry|December 2, 2011
(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addictionYue Pan, Madina R Gerasimov, Trine Kvist, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 30, 2018
The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemiaAndrew N Clarkson, Lily Boothman-Burrell, Zita Dósa, et al.
Brain Communications|February 15, 2021
Gain-of-function <i>GABRB3</i> variants identified in vigabatrin-hypersensitive epileptic encephalopathiesNathan L Absalom, Vivian W Y Liao, Kavitha Kothur, et al.
Brain : a Journal of Neurology|October 11, 2021
Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsyPhilip K Ahring, Vivian W Y Liao, Elena Gardella, et al.
Brain : a Journal of Neurology|April 22, 2026
Collapse of feed-forward inhibition underpins hyperexcitability in GABAA gain-of-function epilepsyChaseley E McKenzie, Khaing Phyu Aung, Altair Brito Dos Santos, et al.
Ebiomedicine|July 12, 2024
Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variantsNazanin Azarinejad Mohammadi, Philip Kiær Ahring, Vivian Wan Yu Liao, et al.
Brain : a Journal of Neurology|June 5, 2025
The genetic and phenotypic spectrum of GABRB1-related disordersCharissa Millevert, Anthony Sze Hon Kan, Moritz Hanke, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
British Journal of Pharmacology|August 12, 2021
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsyLyndsey L Anderson, Marika Heblinski, Nathan L Absalom, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2024
Understanding paralogous epilepsy-associated GABA<sub>A</sub> receptor variants: Clinical implications, mechanisms, and potential pitfallsAnthony S H Kan, Ali S Kusay, Nazanin A Mohammadi, et al.
Epilepsia|June 2, 2026
Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variantsCathrine E Gjerulfsen, Vivian W Y Liao, Tomasz S Mieszczanek, et al.
Journal of Medicinal Chemistry|December 2, 2011
(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addictionYue Pan, Madina R Gerasimov, Trine Kvist, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 30, 2018
The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemiaAndrew N Clarkson, Lily Boothman-Burrell, Zita Dósa, et al.
Brain Communications|February 15, 2021
Gain-of-function <i>GABRB3</i> variants identified in vigabatrin-hypersensitive epileptic encephalopathiesNathan L Absalom, Vivian W Y Liao, Kavitha Kothur, et al.
Brain : a Journal of Neurology|October 11, 2021
Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsyPhilip K Ahring, Vivian W Y Liao, Elena Gardella, et al.
Brain : a Journal of Neurology|April 22, 2026
Collapse of feed-forward inhibition underpins hyperexcitability in GABAA gain-of-function epilepsyChaseley E McKenzie, Khaing Phyu Aung, Altair Brito Dos Santos, et al.
Ebiomedicine|July 12, 2024
Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variantsNazanin Azarinejad Mohammadi, Philip Kiær Ahring, Vivian Wan Yu Liao, et al.
Brain : a Journal of Neurology|June 5, 2025
The genetic and phenotypic spectrum of GABRB1-related disordersCharissa Millevert, Anthony Sze Hon Kan, Moritz Hanke, et al.
Pageof 13